Metronidazole in the prevention of anaerobic infection

Area of Science:

• Surgical Infections and Microbiology
• Pharmacology

Background:

• Surgical sepsis is a frequent complication following appendectomy, colorectal, and gynecologic surgeries.
• Incidence rates for surgical sepsis range from 2% to 60% depending on the surgical procedure and appendix condition.
• Non-spore-forming anaerobes are increasingly recognized as primary culprits in serious postoperative sepsis.

Purpose of the Study:

• To evaluate the efficacy of metronidazole in preventing postoperative morbidity.
• To highlight the role of anaerobic bacteria in surgical sepsis.
• To assess the impact of metronidazole on surgical approaches.

Main Methods:

• Clinical studies conducted at Luton and Dunstable Hospital and other centers.
• Investigated the use of metronidazole, an anaerobicidal agent.
• Assessed the impact on postoperative morbidity related to anaerobic infections.

Main Results:

• Metronidazole demonstrated high effectiveness in preventing postoperative morbidity.
• The agent specifically targets anaerobic organisms, showing minimal activity against aerobic bacteria.
• The use of metronidazole has led to significant modifications in surgical management strategies.

Conclusions:

• Metronidazole is a highly effective prophylactic agent against anaerobic infections in major surgeries.
• Its targeted action against anaerobes makes it crucial for reducing surgical sepsis.
• The drug has positively influenced surgical practice for various conditions.